New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) – A pilot preclinical study
-
Published:2021-09
Issue:
Volume:38
Page:101634
-
ISSN:0960-7404
-
Container-title:Surgical Oncology
-
language:en
-
Short-container-title:Surgical Oncology
Author:
Rudno-Rudzińska Julia,
Kielan Wojciech,
Guziński Maciej,
Płochocki Maciej,
Antończyk Agnieszka,
Kulbacka JulitaORCID
Reference66 articles.
1. Cancer statistics, 2018;Siegel;Ca - Cancer J. Clin.,2018
2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Canc. Res.,2014
3. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030;Quante;Cancer Med,2016
4. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Pourshams;Lancet Gastroenterol. Hepatol,2019
5. Neoadjuvant and adjuvant chemotherapy in pancreatic cancer;Klaiber;Langenbeck's Arch. Surg.,2018
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献